Fortress Biotech, Inc.

FBIO · Nasdaq · SIC 2834: Pharmaceutical Preparations
347
SEC Filings

Business Summary

. 7 Item 1A . Risk Factors 28 Item1B. Unresolved Staff Comments 71 Item 1C . Cybersecurity 71 Item2. Properties 72 Item3. Legal Proceedings 73 Item4. Mine Safety Disclosures 73 PARTII 73 Item5. Market for Registrants Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities 73 Item6. Reserved 73 Item7. Managements Discussion and Analysis of Financial Condition and Results of Operations. 74 Item7A. Quantitative and Qualitative Disclosures About Market Risk. 94 Item8. Fi...

Next Earnings

Q2 FY2026 — expected 2026-09-19

Key Facts from Earnings Calls

TypeSubjectDetailQuarter
topic_mentionFBIOdiscussed_in_filing Cybersecurity
topic_mentionFBIOdiscussed_in_filing Cybersecurity
topic_mentionFBIOdiscussed_in_filing Cybersecurity
topic_mentionFBIOdiscussed_in_filing Cybersecurity

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-03-312025-12-310001104659-26-037874EDGAR107K words
2025-03-312024-12-310001558370-25-004160EDGAR—
2024-03-282023-12-310001558370-24-004272EDGAR—
2023-03-312022-12-310001558370-23-005282EDGAR—
2022-03-282021-12-310001558370-22-004487EDGAR—
2021-03-312020-12-310001558370-21-003815EDGAR—
2020-03-162019-12-310001104659-20-034133EDGAR—
2019-03-182018-12-310001144204-19-014617EDGAR—
2018-03-162017-12-310001144204-18-015301EDGAR—
2017-03-162016-12-310001144204-17-015137EDGAR—

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2025-11-142025-09-300001104659-25-111989EDGAR75K words
2025-08-142025-06-300001558370-25-011570EDGAR—
2025-05-152025-03-310001558370-25-007898EDGAR—
2024-11-142024-09-300001558370-24-015740EDGAR—
2024-08-132024-06-300001558370-24-012063EDGAR—
2024-05-152024-03-310001558370-24-008299EDGAR—
2023-11-142023-09-300001558370-23-019050EDGAR—
2023-08-142023-06-300001558370-23-014854EDGAR—
2023-05-152023-03-310001558370-23-009855EDGAR—
2022-11-142022-09-300001558370-22-017763EDGAR—
2022-08-112022-06-300001558370-22-013275EDGAR—
2022-05-122022-03-310001558370-22-008557EDGAR—

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-03-310001104659-26-037749EDGAR4K words
2026-03-300001104659-26-036818EDGAR—
2026-02-230001104659-26-018371EDGAR—
2026-01-130001104659-26-003121EDGAR—
2025-12-150001104659-25-121187EDGAR—
2025-12-150001104659-25-120893EDGAR—
2025-11-170001104659-25-112945EDGAR—
2025-11-140001104659-25-111979EDGAR—
2025-10-010001104659-25-095366EDGAR—
2025-08-140001558370-25-011561EDGAR—

347 total filings indexed. 315 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

SXTP — 60 DEGREES PHARMACEUTICALS, INC. ABT — ABBOTT LABORATORIES ABEO — ABEONA THERAPEUTICS INC. ABVC — ABVC BIOPHARMA, INC. ACAD — ACADIA PHARMACEUTICALS INC ACTU — ACTUATE THERAPEUTICS, INC. ADCT — ADC Therapeutics SA ADIL — ADIAL PHARMACEUTICALS, INC.

Company Identity

CIK0001429260
TickerFBIO
ExchangeNasdaq
SIC2834: Pharmaceutical Preparations
IncorporatedDE

Get More Data

This is the free public profile. For structured JSON with full provenance chain, use the API:

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: 98ffc800da3efbc8f479290db2510106b4ffe6d649fde2af6be1104e2a9a0a0f
parent: 3379fc8f8c4fa9a25ef13d2452683df670ad427d692dfb6733593d103c963f5d
content hash: bc9253eb94b92967b8ac7d894f33a310818414ad9146ba0c97275bb65818b4e1
signed: 2026-04-13T04:44:59.255Z
sources: 22 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf